4.7 Review

Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?

Iason Psilopatis et al.

Summary: Unresectable hepatocellular carcinoma (HCC) is a poor-prognosis advanced primary liver malignancy. The FDA has approved several monoclonal antibodies (mAbs) including nivolumab, pembrolizumab, ramucirumab, nivolumab/ipilimumab, atezolizumab/bevacizumab, and tremelimumab/durvalumab as first- or second-line therapies for unresectable HCC. This review provides an update on the safety and efficacy of these mAbs, aiming to determine their suitability for different patient subgroups.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Oncology

Hypoxia-associated circPRDM4 promotes immune escape via HIF-1α regulation of PD-L1 in hepatocellular carcinoma

Zhi-Qiang Chen et al.

Summary: This study discovered a hypoxia-associated circular RNA (circPRDM4) in hepatocellular carcinoma (HCC), which promoted immune escape of HCC cells by facilitating the recruitment of HIF-1 alpha onto the promoter of CD274, leading to increased expression of PD-L1. These findings provide a novel prognostic biomarker and therapeutic candidate for HCC immunotherapy.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

Circ_0091579 Knockdown Inhibited HCC Proliferation and Glutamine Metabolism Through miR-1270/YAP1 Axis

Ming Liu et al.

Summary: This study found that circ_0091579 is upregulated in HCC and inhibiting its expression can suppress cell proliferation and promote apoptosis in HCC cells, as well as inhibit tumor growth. Circ_0091579 promotes HCC progression by regulating the miR-1270/YAP1 axis.

BIOCHEMICAL GENETICS (2023)

Article Oncology

CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity

Lu-Lu Yu et al.

Summary: Tumor immunotherapy is revolutionizing cancer treatment, and circular RNAs (circRNAs) are emerging as important players in this field. circRNAs are stable, tissue-specific non-coding RNAs that are involved in the regulation of innate and adaptive immunity. They have significant impact on macrophage, NK, and T cell function, and could serve as biomarkers and therapeutic targets in cancer immunotherapy.

CANCER LETTERS (2023)

Article Biochemistry & Molecular Biology

Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma

Zongqiang Hu et al.

Summary: The study found that circCCAR1, a circular RNA, is present at high levels in tumor tissues and plasma of hepatocellular carcinoma (HCC) patients. CircCCAR1 promotes the growth and metastasis of HCC through the miR-127-5p/WTAP signaling pathway, and causes CD8+ T-cell dysfunction. Moreover, circCCAR1 enhances resistance to anti-PD1 immunotherapy by stabilizing the PD-1 protein and impairing CD8+ T-cell function.

MOLECULAR CANCER (2023)

Article Oncology

MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer

Radwa Y. Mekky et al.

Summary: This study aims to explore the immunogenic role of MALAT-1 in triple negative breast cancer (TNBC) patients and cell lines and identify its molecular mechanism in altering innate and adaptive immune cells present at the tumor microenvironment of TNBC. The results showed that MALAT-1 expression was significantly upregulated in TNBC patients and correlated positively with tumor size and lymph node metastasis. Knocking down MALAT-1 induced the expression of MICA/B and repressed PD-L1 and B7-H4 expression levels, enhancing the cytotoxic activity of immune cells. miR-34a and miR-17-5p were identified as potential targets of MALAT-1 and their downregulation in TNBC patients was observed. This study reveals the immunosuppressive role of MALAT-1 in TNBC through targeting miR-34a/MICA/B and miR-175p/PD-L1/B7-H4 axes.

TRANSLATIONAL ONCOLOGY (2023)

Review Gastroenterology & Hepatology

Immunotherapy for hepatocellular carcinoma: Current status and future perspectives

Deepa S. Mandlik et al.

Summary: Hepatocellular carcinoma (HCC) is a deadly and fast-growing tumor. Current treatments for advanced HCC are limited and ineffective. However, immunotherapy has shown promise in treating HCC and provides new treatment options.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

Editorial: Recent breakthroughs in the decoding of circulating nucleic acids and their applications to human diseases

Sherien M. El-Daly et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2023)

Article Engineering, Biomedical

Drugless nanoparticles tune-up an array of intertwined pathways contributing to immune checkpoint signaling and metabolic reprogramming in triple-negative breast cancer

Asmaa Ramzy et al.

Summary: This study investigated the role of hybrid nanoparticles on the immunosuppressive characteristics of triple-negative breast cancer (TNBC) cells. The results showed that hybrid nanoparticles could convert the immunosuppressive microenvironment of TNBC to an immune-active microenvironment by reducing PD-L1 expression and reversing the Warburg effect.

BIOMEDICAL MATERIALS (2023)

Review Cell Biology

Decoding hepatocarcinogenesis from a noncoding RNAs perspective

Mostafa K. Abd El-Aziz et al.

Summary: The underlying mechanisms of hepatocellular carcinoma (HCC) are poorly understood, and the roles of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in HCC have been less investigated compared to coding genes and microRNAs. However, dysregulation of lncRNAs plays a significant role in HCC progression, making it an important research topic for potential diagnostic and prognostic biomarkers, as well as drug development.

JOURNAL OF CELLULAR PHYSIOLOGY (2023)

Article Biochemistry & Molecular Biology

Circular RNAs: New layer of complexity evading breast cancer heterogeneity

Alyaa Dawoud et al.

Summary: Advances in high-throughput sequencing techniques and bioinformatic analysis have refuted the junk RNA hypothesis and highlighted the importance of circular RNAs (circRNAs) as stable epigenetic regulators. This review focuses on the role of circRNAs in breast cancer, including their potential as diagnostic and prognostic biomarkers, as well as novel therapeutic targets.

NON-CODING RNA RESEARCH (2023)

Article Oncology

Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis

Aya H. Soliman et al.

Summary: This study demonstrates the potential of using nutraceuticals in combination with PDT to remodel the tumor microenvironment in melanoma. By repolarizing TAMs from pro-tumor M2 phenotype to anti-tumor M1 phenotype, the combination therapy not only improves treatment efficacy but also enhances anti-tumor immune responses through modulation of the immune regulatory axis.

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2023)

Article Biochemistry & Molecular Biology

PNPLA3 and IL 28B signature for predicting susceptibility to chronic hepatitis C infection and fibrosis progression

Samar Samir Youssef et al.

Summary: IL28B rs8099917 and PNPLA3 rs738409 polymorphisms are associated with susceptibility to CHC and fibrosis progression in CHC G4. The CC-GG (PNPLA3-IL28B) haplotype is a high-risk signature for CHC infection susceptibility, while the GG-GG (PNPLA3-IL28B) haplotype is a high-risk signature for higher degree of fibrosis.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Clinical Neurology

How to diagnose and manage neurological toxicities of immune checkpoint inhibitors: an update

Alberto Vogrig et al.

Summary: Neurological immune-related adverse events (n-irAEs) are rare but severe complications, with a mortality and morbidity burden for the small percentage of patients who develop severe forms. The diagnosis of n-irAEs is challenging and requires a tailored approach based on the presentation, clinical history, and known specificities. Various patterns of n-irAEs are emerging with distinct clinical, immunological, and prognostic characteristics.

JOURNAL OF NEUROLOGY (2022)

Article Gastroenterology & Hepatology

Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis

Di Zhang et al.

Summary: This study revealed that circ_0091579 promotes the progression of HCC by regulating the miR-1225-5p/PLCB1 axis, providing a novel molecular basis for HCC development.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Cell Biology

MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer

Mustafa Abdel-Latif et al.

Summary: This study demonstrates that methoxylated quercetin glycoside (MQG) can serve as an anti-cancer agent by suppressing TNBC hallmarks, activating immune cell recognition, and alleviating the immune-suppressive tumor microenvironment experienced by TNBC patients.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)

Article Oncology

Hindering the Synchronization Between miR-486-5p and H19 lncRNA by Hesperetin Halts Breast Cancer Aggressiveness Through Tuning ICAM-1

Ramah M. Abdallah et al.

Summary: This study investigated the impact of hesperitin on the miR-486-5p/H19/ICAM-1 axis and found that miR-486-5p and H19 had an inter-connected expression pattern in breast cancer patients. Hesperitin was able to restore miR-486-5p expression, inhibit H19 lncRNA and ICAM-1 expression, and suppress the aggressiveness of mBC cells.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2022)

Article Biotechnology & Applied Microbiology

Circular RNA hsa_circ_0032683 inhibits the progression of hepatocellular carcinoma by sponging microRNA-338-5p

Hao Shen et al.

Summary: This study found that hsa_circ_0032683 has the ability to inhibit proliferation and promote apoptosis in HCC, by competitively regulating the RTN4 gene. This provides potential therapeutic targets and biomarkers for HCC patients.

BIOENGINEERED (2022)

Article Oncology

CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma

Juan Cai et al.

Summary: Inhibition of circRHBDD1 may enhance the efficacy of anti-PD-1 therapy for hepatocellular carcinoma.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Article Pharmacology & Pharmacy

Impact of circ-0000221 in the Pathogenesis of Hepatocellular via Modulation of miR-661-PTPN11 mRNA Axis

Marwa Matboli et al.

Summary: Hepatocellular carcinoma (HCC) is a major cause of cancer-related death in Egypt. This study reveals a novel axis involving hsa-circ-0000221, miR-661, and PTPN11 mRNA in HCC pathogenesis, suggesting a tumor-suppressive role of hsa-circ-0000221 through miR-661 inhibition and subsequent PTPN11 mRNA increase. The findings highlight the potential use of circRNAs as molecular biomarkers in cancer research.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Circ_0091579 exerts an oncogenic role in hepatocellular carcinoma via mediating miR-136- 5p/TRIM27

Yantao Mao et al.

Summary: This study reveals that circ_0091579 plays an oncogenic role in enhancing the malignant potential of hepatocellular carcinoma (HCC) cells by mediating the miR-136-5p/TRIM27 axis both in vitro and in vivo.

BIOMEDICAL JOURNAL (2022)

Article Gastroenterology & Hepatology

Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma

Xia Li et al.

Summary: This study revealed that circ_0001955 may play a positive role in HCC progression by regulating the miR-646/FZD4 axis, indicating its potential as a therapeutic target for HCC.

DIGESTIVE DISEASES AND SCIENCES (2022)

Article Biochemistry & Molecular Biology

CircRNA608-microRNA222-PINK1 axis regulates the mitophagy of hepatic stellate cells in NASH related fibrosis

Zi-Xin Xu et al.

Summary: The study identified the involvement of the circ608-miR222-PINK1 pathway in NASH-related liver fibrosis, specifically in regulating mitophagy. Circ608 was found to inhibit the expression of miR222, thereby promoting PINK1-mediated mitophagy.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Oncology

Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells

Mingyao Huang et al.

Summary: Exosomal circGSE1 derived from hepatocellular carcinoma (HCC) cells promotes HCC progression by inducing expansion of regulatory T cells (Tregs) via the miR-324-5p/TGFBR1/Smad3 axis.

CANCER SCIENCE (2022)

Article Cell Biology

Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184

Xuan Guo et al.

Summary: This article investigates the role and biological function of circular RNA (circRNA) in the occurrence of hepatocellular carcinoma (HCC). The study found that circITCH is downregulated in HCC cells and regulates proliferation, invasion, and apoptosis of HCC through interaction with miR-184. Additionally, circITCH may serve as a potential prognostic marker and therapeutic target for HCC.

CELL CYCLE (2022)

Review Oncology

Cancer vaccines as promising immuno-therapeutics: platforms and current progress

Jian Liu et al.

Summary: Research on tumor immunotherapy has made significant progress, and cancer vaccines have emerged as a promising therapeutic strategy. Cancer vaccines stimulate anti-tumor immunity with tumor antigens, potentially overcoming immune suppression and inducing both humoral and cellular immunity. This review introduces the working mechanism of cancer vaccines, summarizes different development platforms, and highlights their clinical research progress, with a focus on clinical application and therapeutic efficacy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Pharmacology & Pharmacy

miR-516a-3P, a potential circulating biomarker in hepatocellular carcinoma, correlated with rs738409 polymorphism in PNPLA3

Samar Samir Youssef et al.

Summary: This study demonstrates for the first time that miR-516a-3p is differentially expressed in HCV and liver cancer patients and can be used to distinguish between them, potentially allowing for early detection of HCC. Additionally, the PNPLA3 gene rs738409 genotype may have a trans-eQTL effect on the expression of miR-516a-3p in HCV patients.

PERSONALIZED MEDICINE (2022)

Review Oncology

Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery

Sherif Ashraf Fahmy et al.

Summary: Pediatric brain tumors are a significant challenge in the field of oncology. The molecular sub-types of pediatric brain tumors and their oncogenic pathways are not fully understood. This review discusses novel therapeutic targets for different sub-types of pediatric brain tumors and highlights the potential role of hydrogen sulfide (H2S) in these tumors. The review also emphasizes the need for better brain-delivery strategies to improve therapeutic results for brain tumor patients.

CANCERS (2022)

Review Cardiac & Cardiovascular Systems

Immune Checkpoint Inhibitors Related to Cardiotoxicity

Ru Chen et al.

Summary: This review summarizes the current classifications, manifestations, potential mechanisms, and treatment for immune checkpoint inhibitor-related myocardial injury, providing some clues for the understanding of cardiac immune-related adverse effects in clinical practice.

JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2022)

Article Chemistry, Applied

An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR-20a-MICA/B axis

Aya R. Awad et al.

Summary: The natural compound 3'-O-acetylvitexin has shown promising therapeutic effects on TNBC cells by repressing miR-20a and increasing MICA/B expression, indicating its potential as a therapeutic agent for TNBC patients.

NATURAL PRODUCT RESEARCH (2021)

Article Multidisciplinary Sciences

Targeting hydrogen sulphide signaling in breast cancer

Rana Ahmed Youness et al.

Summary: Hydrogen sulphide (H2S) plays a significant role in the pathogenesis of breast cancer, and targeting H2S can mitigate the disease. Knockdown of H2S-synthesizing enzymes in specific types of breast cancer cells resulted in reduced malignancy and increased susceptibility to cytotoxic activity of immune cells. Computational analysis revealed H2S signaling pathways in different breast cancer cell lines and identified a potential upstream regulator that could synergistically abrogate cancer cell malignancy.

JOURNAL OF ADVANCED RESEARCH (2021)

Article Gastroenterology & Hepatology

Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis

Chenggang Ji et al.

Summary: Circ_0091581 acts as an oncogene in HCC, promoting cell viability, colony formation, metastasis, and cell cycle progression while inhibiting apoptosis. It interacts with miR-591 to regulate downstream target FOSL2, ultimately affecting tumor growth and progression in HCC.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Cell Biology

LncRNA HEIH/miR-939-5p interplay modulates triple-negative breast cancer progression through NOS2-induced nitric oxide production

Heba Nafea et al.

Summary: This study identified miR-939-5p as a tumor suppressor miRNA and HEIH as an oncogenic lncRNA in TNBC, showing their regulatory roles in the NO machinery system. Knocking down HEIH improved the immunogenic profile of TNBC cells by inducing MICA/B and suppressing PDL1, and also alleviated the immune-suppressive tumor microenvironment by repressing interleukin-10 and tumor necrosis factor-alpha levels.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Oncology

Amplification of spatially isolated adenosine pathway by tumor-macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma

Jia-Cheng Lu et al.

Summary: This study revealed that elevated circTMEM181 in HCC patients contributes to poor response to anti-PD1 therapy and prognosis. High levels of exosomal circTMEM181 facilitate an immunosuppressive microenvironment and resistance to anti-PD1 therapy in HCC by sponging miR-488-3p and upregulating CD39 in macrophages. Targeting CD39 in macrophages to inhibit the ATP-adenosine pathway may overcome anti-PD1 resistance in HCC.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Oncology

circ-SIRT1 Promotes Colorectal Cancer Proliferation and EMT by Recruiting and Binding to eIF4A3

Xiangjie Wang et al.

Summary: This study identified the high expression of circ-SIRT1 in CRC cells and tissues, and revealed its involvement in promoting proliferation, invasion, and EMT of CRC cells through the circ-SIRT1/EIF4A3/N-cadherin/vimentin pathway.

ANALYTICAL CELLULAR PATHOLOGY (2021)

Review Oncology

The Latest Overview of circRNA in the Progression, Diagnosis, Prognosis, Treatment, and Drug Resistance of Hepatocellular Carcinoma

Dandan Xiong et al.

Summary: Hepatocellular carcinoma (HCC) is a leading cause of tumor-related deaths worldwide, with difficulty in early diagnosis and poor treatment outcomes. Circular RNA (circRNA) has been shown to play a significant role in the pathogenesis and treatment of HCC.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

CircRNA in cancer: Fundamental mechanism and clinical potential

Liang Chen et al.

Summary: Circular RNAs play crucial roles in tumorigenesis and tumor development by promoting or suppressing cancers through different molecular mechanisms. With advancements in nucleic acid-based therapeutic tools, circRNAs could be explored as targetable molecules in future cancer treatments.

CANCER LETTERS (2021)

Review Biochemical Research Methods

Non-coding RNA in cancer

Huiwen Yan et al.

Summary: The majority of the human genome is transcribed into non-coding RNAs (ncRNAs) that play crucial roles in regulating cancer initiation and progression. This review focuses on recent studies of the function, regulatory mechanisms, and therapeutic potential of ncRNAs such as microRNA (miRNA), long ncRNA (lncRNA), circular RNA (circRNA), and PIWI interacting RNA (piRNA) in various types of cancers.

NON-CODING GENOME (2021)

Article Oncology

FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib

May Tun Saung et al.

Summary: The FDA granted accelerated approval to nivolumab in combination with ipilimumab for the treatment of HCC based on data from cohort 4 of Check-Mate 040, showing comparable BICR-assessed ORR in all three arms at 31%-32%. Adverse events were consistent with known profiles of nivolumab and ipilimumab, with no new safety events identified.

ONCOLOGIST (2021)

Article Multidisciplinary Sciences

PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy

Julia Koerner et al.

Summary: PLGA-based cancer immunotherapy incorporating antigens and TLR ligands has led to enhanced anti-tumor responses. The study explores the use of a defined dsRNA adjuvant, Riboxxim, and demonstrates its incorporation with PLGA immunotherapy in in vivo tumor models, resulting in enhanced induction of anti-tumor response.

NATURE COMMUNICATIONS (2021)

Article Biochemistry & Molecular Biology

What is beyond LncRNAs in breast cancer: A special focus on colon cancer-associated Transcript-1 (CCAT-1)

Noha A. Selem et al.

Summary: This review focuses on the role of long non-coding RNAs in breast cancer, with a specific emphasis on triple negative breast cancer patients and associated LncRNAs.

NON-CODING RNA RESEARCH (2021)

Article Medicine, General & Internal

Immune checkpoint inhibitors in melanoma

Matteo S Carlino et al.

LANCET (2021)

Review Gastroenterology & Hepatology

Immune checkpoint inhibitor-related hepatotoxicity: A review

Devika Remash et al.

Summary: The use of immune checkpoint inhibitors in cancer treatment has advanced significantly, but adverse events such as immune checkpoint inhibitor-related hepatotoxicity can occur and require prompt investigation and management.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Medicine, Research & Experimental

Circular RNA circ-TNPO3 suppresses metastasis of GC by acting as a protein decoy for IGF2BP3 to regulate the expression of MYC and SNAIL

Ting Yu et al.

Summary: The study revealed that circ-TNPO3 plays a crucial inhibitory role in gastric cancer by regulating the MYC-SNAIL pathway to suppress proliferation and metastasis.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Oncology

Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression

Maria Papatsirou et al.

Summary: Signal transduction is crucial for regulating fundamental cellular processes, and circRNAs are emerging as a type of endogenous transcripts with regulatory roles in various diseases, including cancer. Aberrantly expressed circRNAs can mediate cancer progression by impacting the activity of major signaling cascades.

CANCERS (2021)

Article Oncology

FDA Approval Summary: Atezolizumab Plus Bevacizumab for the Treatment of Patients with Advanced Unresectable or Metastatic Hepatocellular Carcinoma

Sandra J. Casak et al.

Summary: The FDA approved atezolizumab in combination with bevacizumab for the treatment of unresectable hepatocellular carcinoma. The approval was based on Study IMbrave150 which showed improved overall survival and progression-free survival compared to standard care with sorafenib. Adverse reactions included hypertension, fatigue, and proteinuria.

CLINICAL CANCER RESEARCH (2021)

Article Cell & Tissue Engineering

Circ SMARCA5 Inhibited Tumor Metastasis by Interacting with SND1 and Downregulating the YWHAB Gene in Cervical Cancer

Xia Zhang et al.

Summary: Overexpression of circ SMARCA5 inhibits proliferation and invasion of cervical cancer cells while promoting apoptosis, ultimately inhibiting metastasis.

CELL TRANSPLANTATION (2021)

Article Medicine, Research & Experimental

Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875-3p and miR-421

Wei Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Biochemistry & Molecular Biology

Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma

Gustavo Ferrin et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Chemistry, Applied

A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner

Rana Ahmed Youness et al.

NATURAL PRODUCT RESEARCH (2020)

Article Oncology

Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis

Xiu-Yan Huang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Review Biochemistry & Molecular Biology

Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application

Le Zhang et al.

MOLECULAR CANCER (2020)

Review Genetics & Heredity

Molecular Mechanisms Driving mRNA Degradation by m(6)A Modification

Yujin Lee et al.

TRENDS IN GENETICS (2020)

Review Oncology

Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy

Filippo Galli et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Article Cell Biology

Modulation of circRNA Metabolism by m6A Modification

Gaia Di Timoteo et al.

CELL REPORTS (2020)

Article Medicine, General & Internal

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Biochemistry & Molecular Biology

Immune-based therapies for hepatocellular carcinoma

David J. Pinato et al.

ONCOGENE (2020)

Review Cell & Tissue Engineering

Functions of Circular RNAs in Regulating Adipogenesis of Mesenchymal Stem Cells

Fanglin Wang et al.

STEM CELLS INTERNATIONAL (2020)

Review Medicine, Research & Experimental

How to overcome the side effects of tumor immunotherapy

Shang Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Biochemistry & Molecular Biology

CircRNA inhibits DNA damage repair by interacting with host gene

Xiaolong Xu et al.

MOLECULAR CANCER (2020)

Review Pharmacology & Pharmacy

The role of circular RNAs in therapy resistance of patients with solid tumors

Maria Papatsirou et al.

PERSONALIZED MEDICINE (2020)

Article Medicine, Research & Experimental

hsa_circ_0001955 Enhances In Vitro Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis

Bisha Ding et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Review Medical Laboratory Technology

Circular RNAs: Regulatory functions in respiratory tract cancers

Ziyi Peng et al.

CLINICA CHIMICA ACTA (2020)

Review Oncology

Why natural killer cells in triple negative breast cancer?

Mustafa Abdel-Latif et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Oncology

The cancer-natural killer cell immunity cycle

Nicholas D. Huntington et al.

NATURE REVIEWS CANCER (2020)

Article Medicine, Research & Experimental

Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis

Xin Chen et al.

THERANOSTICS (2020)

Article Biochemistry & Molecular Biology

The Landscape of Circular RNA in Cancer

Josh N. Vo et al.

Article Biochemistry & Molecular Biology

Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression

Liyan Wang et al.

MOLECULAR CANCER (2019)

Article Biochemistry & Molecular Biology

Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression

Peng-Fei Zhang et al.

MOLECULAR CANCER (2019)

Article Medicine, Research & Experimental

Circular RNA circHIAT1 inhibits cell growth in hepatocellular carcinoma by regulating miR-3171/PTEN axis

Zhengmiao Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Genetics & Heredity

The biogenesis, biology and characterization of circular RNAs

Lasse S. Kristensen et al.

NATURE REVIEWS GENETICS (2019)

Article Biotechnology & Applied Microbiology

Emerging Roles Of hsa-circ-0046600 Targeting The miR-640/HIF-1α Signalling Pathway In The Progression Of HCC

Zhensheng Zhai et al.

ONCOTARGETS AND THERAPY (2019)

Article Cell Biology

Hsa_circ_101280 promotes hepatocellular carcinoma by regulating miR-375/JAK2

Shuang Cao et al.

IMMUNOLOGY AND CELL BIOLOGY (2019)

Review Hematology

An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer

Steven Feins et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Article Biotechnology & Applied Microbiology

Translation of the circular RNA circ-catenin promotes liver cancer cell growth through activation of the Wnt pathway

Wei-Cheng Liang et al.

GENOME BIOLOGY (2019)

Article Medicine, Research & Experimental

Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC

Ming-fang Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Cell Biology

Emerging role of non-coding RNA in oral cancer

Fatemeh Momen-Heravi et al.

CELLULAR SIGNALLING (2018)

Review Immunology

The immunology of hepatocellular carcinoma

Marc Ringelhan et al.

NATURE IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis

Maolei Zhang et al.

ONCOGENE (2018)

Review Biochemistry & Molecular Biology

Cancer immunotherapy: broadening the scope of targetable tumours

Jitske van den Bulk et al.

OPEN BIOLOGY (2018)

Review Immunology

The Potential Role of circRNA in Tumor Immunity Regulation and Immunotherapy

Zihao Xu et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

Circular RNAs in Cancer - Lessons Learned From microRNAs

Mihnea Dragomir et al.

FRONTIERS IN ONCOLOGY (2018)

Article Oncology

circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346

Ning Bai et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Review Oncology

Advances in circular RNAs and their roles in breast Cancer

Xuehui Wang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Biochemistry & Molecular Biology

A novel role of sONE/NOS3/NO signaling cascade in mediating hydrogen sulphide bilateral effects on triple negative breast cancer progression

Rana Ahmed Youness et al.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity

William W. Du et al.

CELL DEATH AND DIFFERENTIATION (2017)

Review Cell Biology

Regulatory T cells in cancer immunotherapy

Atsushi Tanaka et al.

CELL RESEARCH (2017)

Article Oncology

The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma

Liangliang Xu et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)

Review Neurosciences

Regulatory Role of Circular RNAs and Neurological Disorders

Gabriele Floris et al.

MOLECULAR NEUROBIOLOGY (2017)

Article Biotechnology & Applied Microbiology

Non-coding RNAs as drug targets

Masayuki Matsui et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Review Biotechnology & Applied Microbiology

The emerging role of circular RNAs in transcriptome regulation

S. Huang et al.

GENOMICS (2017)

Article Biochemistry & Molecular Biology

Translation of CircRNAs

Nagarjuna Reddy Pamudurti et al.

MOLECULAR CELL (2017)

Article Biochemistry & Molecular Biology

The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting

Dongming Liang et al.

MOLECULAR CELL (2017)

Article Multidisciplinary Sciences

FUS affects circular RNA expression in murine embryonic stem cell-derived motor neurons

Lorenzo Errichelli et al.

NATURE COMMUNICATIONS (2017)

Article Medicine, Research & Experimental

Silencing Of Circular RNA-ZNF609 Ameliorates Vascular Endothelial Dysfunction

Chang Liu et al.

THERANOSTICS (2017)

Article Biochemistry & Molecular Biology

Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer

Bo Li et al.

JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2017)

Article Cardiac & Cardiovascular Systems

A Novel Regulatory Mechanism of Smooth Muscle α-Actin Expression by NRG-1/circACTA2/miR-548f-5p Axis

Yan Sun et al.

CIRCULATION RESEARCH (2017)

Article Biochemistry & Molecular Biology

Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing

Chunhong Zheng et al.

Article Cell Biology

Extensive translation of circular RNAs driven by N6-methyladenosine

Yun Yang et al.

CELL RESEARCH (2017)

Article Oncology

Circular RNA 0000096 affects cell growth and migration in gastric cancer

Peifei Li et al.

BRITISH JOURNAL OF CANCER (2017)

Review Oncology

Epigenetic alternations and cancer chemotherapy response

Jin-Feng Lv et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Diverse alternative back-splicing and alternative splicing landscape of circular RNAs

Xiao-Ou Zhang et al.

GENOME RESEARCH (2016)

Article Biochemistry & Molecular Biology

The RNA Binding Protein Quaking Regulates Formation of circRNAs

Simon J. Conn et al.

Review Biotechnology & Applied Microbiology

Oncolytic viruses: a new class of immunotherapy drugs

Howard L. Kaufman et al.

NATURE REVIEWS DRUG DISCOVERY (2015)

Article Biochemistry & Molecular Biology

Exon-intron circular RNAs regulate transcription in the nucleus

Zhaoyong Li et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Article Biochemistry & Molecular Biology

Exon-intron circular RNAs regulate transcription in the nucleus

Zhaoyong Li et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)

Review Cell Biology

An intriguing RNA species-perspectives of circularized RNA

Ting Shen et al.

PROTEIN & CELL (2015)

Review Biotechnology & Applied Microbiology

Detecting and characterizing circular RNAs

William R. Jeck et al.

NATURE BIOTECHNOLOGY (2014)

Article Gastroenterology & Hepatology

Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age

Koji Miyahara et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Biotechnology & Applied Microbiology

Expanded identification and characterization of mammalian circular RNAs

Junjie U. Guo et al.

GENOME BIOLOGY (2014)

Review Oncology

Circular RNA and miR-7 in Cancer

Thomas B. Hansen et al.

CANCER RESEARCH (2013)

Article Medical Laboratory Technology

Prostate cancer antigen 3 (PCA3) RNA detection in blood and tissue samples for prostate cancer diagnosis

Adriana F. Neves et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)

Article Biochemistry & Molecular Biology

Circular Intronic Long Noncoding RNAs

Yang Zhang et al.

MOLECULAR CELL (2013)

Article Multidisciplinary Sciences

Natural RNA circles function as efficient microRNA sponges

Thomas B. Hansen et al.

NATURE (2013)

Article Biochemistry & Molecular Biology

Circular RNAs are abundant, conserved, and associated with ALU repeats

William R. Jeck et al.

Article Genetics & Heredity

Correction: Cell-Type Specific Features of Circular RNA Expression

Julia Salzman et al.

PLoS Genetics (2013)

Editorial Material Gastroenterology & Hepatology

Management of Hepatocellular Carcinoma: An Update

Jordi Bruix et al.

HEPATOLOGY (2011)

Review Multidisciplinary Sciences

The Polycomb complex PRC2 and its mark in life

Raphael Margueron et al.

NATURE (2011)

Review Oncology

Cell-free nucleic acids as biomarkers in cancer patients

Heidi Schwarzenbach et al.

NATURE REVIEWS CANCER (2011)

Review Biochemistry & Molecular Biology

Non-coding RNA

JS Mattick et al.

HUMAN MOLECULAR GENETICS (2006)

Review Cell Biology

DNA methylation patterns and epigenetic memory

A Bird

GENES & DEVELOPMENT (2002)